Injection of Autologous Stromal Vascular Fraction enriched lipoaspirate for the treatment of vulvar Lichen Sclerosus - a pilot study - Injection of aSVF enriched lipoaspirate for vulvar Lichen Sclerosus

niversitair Medisch Centrum Groningen0 个研究点目标入组 15 人开始时间: 待定最近更新: 2024年6月11日

适应症

试验速览

暂无简介。

•- Postmenopausal women up to 80 years with ASA Physical Status Classification 0-1
•- Histopathological confirmed diagnosis of lichen sclerosus
•- Moderate or severe lichen sclerosus (IGA scale 3 or 4), therapy resistant to conventional therapy with highly potent topical steroids (insufficient reduction in clinical symptoms and signs having used topical steroids for 6 months).

•- Women with history of vulvar cancer or vulva intraepitheliale neoplasie (VIN) in addition to lichen sclerosus
•- An oncological event in the patient*s history < 5 years ago.
•- A known systemic disease that will impair wound healing (e.g. diabetes mellitus type I, known atherosclerosis with an event that required hospitalization, collagen diseases, diseases of the skin, HIV).
•- Systematic use of prednisone or other immunotherapy
•- Use of anticoagulant therapy

发起方